Cargando…
Targeting intracellular signaling as an antiviral strategy: aerosolized LASAG for the treatment of influenza in hospitalized patients
Influenza has been a long-running health problem and novel antiviral drugs are urgently needed. In pre-clinical studies, we demonstrated broad antiviral activity of D, L-lysine-acetylsalicylate glycine (LASAG) against influenza virus (IV) in cell culture and protection against lethal challenge in mi...
Autores principales: | Scheuch, Gerhard, Canisius, Sebastian, Nocker, Karlheinz, Hofmann, Thomas, Naumann, Rolf, Pleschka, Stephan, Ludwig, Stephan, Welte, Tobias, Planz, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841227/ https://www.ncbi.nlm.nih.gov/pubmed/29511170 http://dx.doi.org/10.1038/s41426-018-0023-3 |
Ejemplares similares
-
Pharmacodynamics, Pharmacokinetics, and Antiviral Activity of BAY 81-8781, a Novel NF-κB Inhibiting Anti-influenza Drug
por: Droebner, Karoline, et al.
Publicado: (2017) -
MEK inhibitors as novel host-targeted antivirals with a
dual-benefit mode of action against hyperinflammatory respiratory viral
diseases
por: Ludwig, Stephan, et al.
Publicado: (2023) -
Anti-viral approaches against influenza viruses
por: Pleschka, Stephan, et al.
Publicado: (2006) -
The influenza replication blocking inhibitor LASAG does not sensitize human epithelial cells for bacterial infections
por: Wilden, Janine J., et al.
Publicado: (2020) -
Improved in vitro Efficacy of Baloxavir Marboxil Against Influenza A Virus Infection by Combination Treatment With the MEK Inhibitor ATR-002
por: Hamza, Hazem, et al.
Publicado: (2021)